The QT variability index identified patients presenting with sudden cardiac death (OR 12.5; P=0.004) and a QTVI ≥0.1 predicted a higher risk of arrhythmic events during follow-up (P<0.05).
Observational (n=95)
Does the QT variability index (QTVI) identify patients at risk for sudden cardiac death or sustained monomorphic ventricular tachycardia?
The QT variability index is a noninvasive measure of temporal repolarization lability that can identify patients at high risk for sudden cardiac death and predict future arrhythmic events.
Effect estimate: OR 12.5
p-value: p=0.004
INTRODUCTION: Recent studies have implicated repolarization lability in the genesis of malignant ventricular arrhythmias. However, few data exist on assessment of temporal QT interval variability and its relation to arrhythmogenesis. We tested the ability of the QT variability index (QTVI), a measure of beat-to-beat QT interval fluctuations measured on a single ECG lead, to identify patients presenting with malignant ventricular arrhythmias and predict their subsequent occurrences. METHODS AND RESULTS: We measured the QTVI in 95 patients presenting for electrophysiologic study (EPS). The ability of the QTVI to identify patients with sudden cardiac death (SCD) or sustained monomorphic ventricular tachycardia (MVT) on presentation and during follow-up of 23.7+/-14.3 months was compared with spatial QT dispersion, T wave alternans ratio during atrial pacing, MVT inducibility at EPS, signal-averaged ECG, heart rate variability, and ejection fraction. The QTVI was higher in patients with heart disease than in controls (-0.7+/-0.7 vs -1.1+/-0.5, P or =0.1 was a discriminator for higher risk of arrhythmic events (P < 0.05). CONCLUSIONS: (1) This noninvasive measure of temporal repolarization lability identified patients with SCD and predicted arrhythmia-free survival. (2) Further studies are needed to determine the mechanisms that mediate beat-to-beat QT interval variability.
Atiga et al. (1998) conducted an observational in Risk for sudden cardiac death or ventricular arrhythmias (n=95). QT variability index (QTVI) vs. Controls and other clinical variables was evaluated on Sudden cardiac death (SCD) or sustained monomorphic ventricular tachycardia (MVT) on presentation and during follow-up (OR 12.5, p=0.004). The QT variability index identified patients presenting with sudden cardiac death (OR 12.5; P=0.004) and a QTVI ≥0.1 predicted a higher risk of arrhythmic events during follow-up (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: